These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22248361)

  • 21. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation.
    Wong B; Lumma WC; Smith AM; Sisko JT; Wright SD; Cai TQ
    J Leukoc Biol; 2001 Jun; 69(6):959-62. PubMed ID: 11404382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
    Qu X; Yuan Y; Xu W; Chen M; Cui S; Meng H; Li Y; Makuuchi M; Nakata M; Tang W
    Anticancer Res; 2006; 26(5A):3573-8. PubMed ID: 17094485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of matrix metalloproteinase-9 by interferons and TGF-beta1 through distinct signalings accounts for reduced monocyte invasiveness.
    Nguyen J; Knapnougel P; Lesavre P; Bauvois B
    FEBS Lett; 2005 Oct; 579(25):5487-93. PubMed ID: 16213498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
    Maquoi E; Munaut C; Colige A; Lambert C; Frankenne F; Noël A; Grams F; Krell HW; Foidart JM
    Exp Cell Res; 2002 Apr; 275(1):110-21. PubMed ID: 11925109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
    Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
    Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases of human NK cells.
    Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
    In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
    Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG
    Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
    Kim MS; Park MJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH
    Int J Oncol; 2005 Sep; 27(3):839-46. PubMed ID: 16077936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.
    Abdel-Aziz M; Abuo-Rahma Gel-D; Beshr EA; Ali TF
    Bioorg Med Chem; 2013 Jul; 21(13):3839-49. PubMed ID: 23665142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells.
    Huber AV; Saleh L; Bauer S; Husslein P; Knöfler M
    Placenta; 2006; 27(2-3):127-36. PubMed ID: 16338458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
    Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
    Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells.
    Ramer R; Eichele K; Hinz B
    Oncogene; 2007 Aug; 26(39):5822-7. PubMed ID: 17369856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship studies of a series of novel delta-lactam-based histone deacetylase inhibitors.
    Kim HM; Ryu DK; Choi Y; Park BW; Lee K; Han SB; Lee CW; Kang MR; Kang JS; Boovanahalli SK; Park SK; Han JW; Chun TG; Lee HY; Nam KY; Choi EH; Han G
    J Med Chem; 2007 May; 50(11):2737-41. PubMed ID: 17477518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.
    Xia M; Leppert D; Hauser SL; Sreedharan SP; Nelson PJ; Krensky AM; Goetzl EJ
    J Immunol; 1996 Jan; 156(1):160-7. PubMed ID: 8598457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
    Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
    Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
    Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9.
    Chabot V; Reverdiau P; Iochmann S; Rico A; Sénécal D; Goupille C; Sizaret PY; Sensebé L
    J Leukoc Biol; 2006 Apr; 79(4):767-78. PubMed ID: 16434695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.
    Lu Z; Lu N; Li C; Li F; Zhao K; Lin B; Guo Q
    Toxicol Lett; 2012 Mar; 209(3):211-20. PubMed ID: 22245252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.